Primary Record
Elagolix
- In stock
- 4,400 g
- Purity
- 98.8 %
- CAS
- 834153-87-6
Compound Identifiers & Properties
- CAS
- 834153-87-6
- PubChem CID
- 11250647
- SMILES
- CC1=C(C(=O)N(C(=O)N1CC2=C(C=CC=C2F)C(F)(F)F)C[C@@H](C3=CC=CC=C3)NCCCC(=O)O)C4=C(C(=CC=C4)OC)F
- Canonical SMILES
- COc1cccc(-c2c(C)n(Cc3c(F)cccc3C(F)(F)F)c(=O)n(C[C@H](NCCCC(=O)O)c3ccccc3)c2=O)c1F
Names & Synonyms
- Elagolix
- (R)-Elagolix
- Orilissa
- Elagolix sodium
- elagolixum
- 834153-87-6
- Elagolix?
- Elagolix [USAN]
- ELA gOLIX
- Elagolix [USAN:INN]
- NBI-56418
- RefChem:58959
- Elagolix (USAN/INN)
- ELAGOLIX [INN]
- ELAGOLIX [MI]
- D0UI3T
- ELAGOLIX [WHO-DD]
- UNII-5B2546MB5Z
- 5B2546MB5Z
- (R)-ElagolixNBI-56418
- ABT-620
- DTXSID40232348
- NBI 56418
- GTPL8362
- orb1309714
- SCHEMBL1642523
- CHEMBL1208155
- NBI56418
- SCHEMBL29365599
- SCHEMBL29396002
- 834153-87-6 (free acid)
- DTXCID40154839
- H01CC03
- CHEBI:177453
- HEAUOKZIVMZVQL-VWLOTQADSA-N
- GLXC-10786
- AMY16504
- BCP08827
- EX-A1765
- BT-620
- EBC-27400
- MFCD11973645
- ZINC49888891
- AKOS040733086
- CS-5329
- DB11979
- CID11250647
- compound 10b [PMID 19006286]
- Elagolix, Elagolix sodium, NBI-56418
- AC-30676
- AN-27202
- CID 11250647
- DA-52850
- HY-14789
- MS-30861
- NS00072618
- J2.888.161D
- D09335
- Z-3253
- 153E876
- A854707
- EN300-19807339
- BRD-K55808645-001-01-4
- Q21098999
- 4-[[(1R)-2-[5-(2-fluoro-3-methoxyphenyl)-3-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-4-methyl-2,6-dioxopyrimidin-1-yl]-1-phenylethyl]amino]butanoic acid
- 4-{[(1R)-2-[5-(2-fluoro-3-methoxyphenyl)-3-{[2-fluoro-6-(trifluoromethyl)phenyl]methyl}-4-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-1-yl]-1-phenylethyl]amino}butanoic acid
- (R)-4-((2-(5-(2-fluoro-3-methoxyphenyl)-3-(2-fluoro-6-(trifluoromethyl)benzyl)-4-methyl-2,6-dioxo-3,6-dihydropyrimidin-1(2H)-yl)-1-phenylethyl)amino)butanoic acid
- 4-[[(1R)-2-[5-(2-fluoranyl-3-methoxy-phenyl)-3-[[2-fluoranyl-6-(trifluoromethyl)phenyl]methyl]-4-methyl-2,6-bis(oxidanylidene)pyrimidin-1-yl]-1-phenyl-ethyl]amino]butanoic acid
- Butanoic acid, 4-(((1R)-2-(5-(2-fluoro-3-methoxyphenyl)-3-((2-fluoro-6-(trifluoromethyl)phenyl)methyl)-3,6-dihydro-4-methyl-2,6-dioxo-1(2H)-pyrimidinyl)-1-phenylethyl)amino)-
- 4-(((1R)-2-(5-(2-FLUORO-3-METHOXYPHENYL)-3-((2-FLUORO-6-(TRIFLUOROMETHYL)PHENYL)METHYL)- 4-METHYL-2,6-DIOXO-3,6-DIHYDROPYRIMIDIN-1(2H)-YL)-1-PHENYLETHYL)AMINO)BUTANOIC ACID
- 4-(((1R)-2-(5-(2-fluoro-3-methoxyphenyl)-3-((2-fluoro-6-(trifluoromethyl)phenyl)methyl)-4-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-1-yl)-1-phenylethyl)amino)butanoic acid
- 4-(((1R)-2-(5-(2-Fluoro-3-methoxyphenyl)-3-((2-fluoro-6-(trifluoromethyl)phenyl)methyl)-4-methyl-2,6-dioxo-3,6-dihydropyrimidin-1(2H)-yl)-1-phenylethyl)amino)butanoic acid
- 4-(((1R)-2-(5-(2-fluoro-3-methoxyphenyl)-3-((2-fluoro-6-(trifluoromethyl)phenyl)methyl)-4-methyl-2,6-dioxopyrimidin-1-yl)-1-phenylethyl)amino)butanoic acid
- 4-({(1R)-2-[5-(2-Fluoro-3-methoxyphenyl)-3-{[2-fluoro-6-(trifluoromethyl)phenyl]methyl}-4-methyl-2,6-dioxo-3,6-dihydropyrimidin-1(2H)-yl]-1-phenylethyl}amino)butanoic acid
- 4-[[(1R)-1-Phenyl-2-[2,6-dioxo-3-[2-fluoro-6-(trifluoromethyl)benzyl]-4-methyl-5-(2-fluoro-3-methoxyphenyl)-1,2,3,6-tetrahydropyrimidine-1-yl]ethyl]amino]butyric acid
- 4-[[(1R)-2-[5-(2-fluoro-3-methoxy-phenyl)-3-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-4-methyl-2,6-dioxo-pyrimidin-1-yl]-1-phenyl-ethyl]amino]butanoic acid
- 4-[[(1R)-2-[5-(2-luoro-3-methoxyphenyl)-3-[[2-luoro-6-(triluoromethyl)phenyl]methyl]-4-methyl-2,6-dioxopyrimidin-1-yl]-1-phenylethyl]amino]butanoic acid
- 832720-36-2
- BUTANOIC ACID, 4-(((1R)-2-(5-(2-FLUORO-3-METHOXYPHENYL)-3-((2-FLUORO-6-(TRIFLUOROMETHYL)PHENYL)METHYL)-3,6-DIHYDRO-4-METHYL-2,6-DIOXO-1(2H)-PYRIMIDINYL)-1- PHENYLETHYL)AMINO)-
- Elagolix; Butanoic acid, 4-[[(1R)-2-[5-(2-fluoro-3-methoxyphenyl)-3-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-3,6-dihydro-4-methyl-2,6-dioxo-1(2H)-pyrimidinyl]-1-phenylethyl]amino]-; 4-[[(1R)-2-[5-(2-Fluoro-3-methoxyphenyl)-3-[[2-fluoro-6-(trifluoromethyl)phenyl
- F5O